Open access · CC-BY
via OpenAlex
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
Nobuyuki Toshikuni, Kazuhiro Nouso, Toshihiro Higashi, Hideki Nakatsukasa, T Onishi, Toshihiko Kaneyoshi, Yoshihisa Kobayashi, Kazuya Kariyama, Ken Yamamoto, Toshiya Tsuji
British Journal of Cancer · 2000 · ▲ 45 citations
Abstract
To know whether two protein components of human telomerase (human telomerase-associated protein 1 (hTEP1) and human telomerase reverse transcriptase (hTERT) are useful markers for telomerase activation in human liver diseases, we examined mRNA levels of these and telomerase activity in human liver samples. Twenty-three human hepatocellular carcinomas (HCCs) and corresponding adjacent livers were analysed for hTEP1 and hTERT expression by semiquantitative reverse transcription-polymerase chain reaction, and for telomerase activity by a telomeric repeat amplification protocol assay. Thirteen liver samples (ten HCCs and three dysplastic nodules) that were biopsied with 21-gauge needles were analysed for hTERT expression. hTEP1 was expressed in all samples examined. No correlation between hTEP1 expression and telomerase activity was observed. hTERT expression significantly correlated with telomerase activity (P< 0.001). The positivity of hTERT for HCC and corresponding non-cancerous liver was 100% and 30.4% respectively (P < 0.001). Seventy-four per cent (17/23) of HCCs showed strong hTERT expression, but none of the non-cancerous liver tissues did. hTERT expression of the 21-gauge needle biopsied specimens showed no significant difference from that of the surgical samples. The present study revealed that hTERT is strongly expressed in most HCCs, and that hTERT but not hTEP1 is a key component regulating telomerase activity in human liver.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1054/bjoc.1999.1008
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Toshikuni, N., Nouso, K., Higashi, T., Nakatsukasa, H., Onishi, T., Kaneyoshi, T., Kobayashi, Y., Kariyama, K., Yamamoto, K., & Tsuji, T. (2000). Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. <em>British Journal of Cancer</em>. https://doi.org/10.1054/bjoc.1999.1008
Vancouver
Toshikuni N, Nouso K, Higashi T, Nakatsukasa H, Onishi T, Kaneyoshi T, et al. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. British Journal of Cancer. 2000. doi:10.1054/bjoc.1999.1008.
BibTeX
@article{nobuyuki2000Expres,
title = {Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma},
author = {Nobuyuki Toshikuni and Kazuhiro Nouso and Toshihiro Higashi and Hideki Nakatsukasa and T Onishi and Toshihiko Kaneyoshi and Yoshihisa Kobayashi and Kazuya Kariyama and Ken Yamamoto and Toshiya Tsuji},
journal = {British Journal of Cancer},
year = {2000},
doi = {10.1054/bjoc.1999.1008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experimental and Therapeutic Medicine 2013
Open access · OA
Aspirin inhibits human telomerase activation in unstable carotid plaques
Cancer 2002
Open access · OA
Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma
Modern Pathology 2003
Open access · OA
Expression of Telomerase Activity, Human Telomerase RNA, and Telomerase Reverse Transcriptase in Gastric Adenocarcinomas
Experimental & Molecular Medicine 1998
Open access · CC-BY
Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis
British Journal of Cancer 2004
Open access · CC-BY
Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours
Cancer Research 2007
Open access · OA